Synendos Therapeutics AG Company Profile, Contacts & Intelligence

Synendos Therapeutics AG Overview

Synendos Therapeutics AG is a biopharmaceutical company founded in April 2019 as a spin-off of the University of Bern. Synendos develops an innovative therapeutic approach based upon first-in-class inhibitors (small molecules) that modulate a new drug target (not yet published). The inhibitors were designed and developed at the University of Bern starting from an in silico screening of 12 million compounds which was followed by a thorough med chem programme in collaboration with a CRO. The inhibitors act with a new mechanism of action that enables restoration of the natural function of the brain by rebalancing altered neurotransmission in different areas of the brain. Our mission is to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders.

Headquarters

Basel, Basel-stadt, Ch

Website

synendos.com

Industry

Pharmaceutical Manufacturing

Founded

2019

NAICS

Pharmaceutical and Medicine Manufacturing, Medicinal and Botanical Manufacturing

Company Email

Available in AeroLeads

Synendos Therapeutics AG Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Synendos Therapeutics AG People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Synendos Therapeutics AG Workforce Composition

Seniority breakdown across 6 visible profiles.

Compare Similar Companies to Synendos Therapeutics AG

Explore companies in related markets and compare their industry and employee estimates.